Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein-serine-threonine kinases are a large group of enzymes that catalyze the transfer of a phosphate group from ATP to serine or threonine residues in protein substrates. This post-translational modification regulates protein function and cellular signaling pathways, influencing activity, stability, localization, and interactions. They play fundamental roles in controlling cell growth, differentiation, metabolism, apoptosis, and synaptic plasticity. Dysregulation is implicated in diseases like cancer, neurodegeneration, and metabolic syndromes, making them major therapeutic targets.
Inhibition of kinase activity, preventing phosphorylation of target proteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein-serine-threonine kinase.